Share This Article:

Prevalence of occult hepatitis C in egyptian patients with non alcoholic fatty liver disease

Abstract Full-Text HTML Download Download as PDF (Size:123KB) PP. 33-37
DOI: 10.4236/ojim.2011.12009    5,204 Downloads   10,493 Views   Citations

ABSTRACT

This study aim is to assess the prevalence of occult HCV infection among Egyptian patients with non alcoholic fatty liver disease (NAFLD) with elevated AST and ALT, and to correlate presence of occult HCV with severity of liver disease. Patients and Methods: After informed consent 27 patients with elevateed liver enzymes diagnosed as NAFLD were examined for demographic, clinical, laboratory data and Ultrasonography. Liver biopsy was done and tested for HCV RNA in tissue. Genotyping using RFLP analysis of PCR products in the 5’NCR was done for positive cases. Results: HCV RNA in tissue was positive in 11/27 patients (40.7%); genotype was 4a in all positive cases. AST and ALT values showed significantly lower values in occult HCV than the non HCV NAFLD group. Liver biopsy of studied patients showed no significant difference as regard inflammation and fibrosis according to METAVIR score. Conclusions: Occult HCV is highly prevalent among Egyptian NAFLD patients. It seems to induce a mild liver disease. Patients with elevated ALT and negative HCV RNA in sera might be investigated for tissue HCV RNA. Follow up is recommended for the occult HCV patients to monitor progression to overt disease.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Saad, Y. , Zakaria, S. , Ramzy, I. , Raziky, M. , Shaker, O. , elakel, W. , Said, M. , Noseir, M. , El-Daly, M. , Hamid, M. and Esmat, G. (2011) Prevalence of occult hepatitis C in egyptian patients with non alcoholic fatty liver disease. Open Journal of Internal Medicine, 1, 33-37. doi: 10.4236/ojim.2011.12009.

References

[1] Berasain, C., Betés, M., Panizo, A., Ruiz, J., Herrero, J.I., Civeira, M.-P. et al. (2000) Pathological and virological findings in patients with aetiology persistent hyper-transaminasaemia of unknown. Gut, 47, 429-435. doi:10.1136/gut.47.3.429
[2] Diodati, G., Pontisso, P., Bonetti, P., Stenico, D., Noventa, F., Alberti, A., et al. (1988) Cryptogenic chronic liver disease and serum or liver hepatitis B virus markers. Their possible correlations and etiologic significance. Digestion, 39, 251-256. doi:10.1159/000199633
[3] Chemin, I., Zoulim, F., Merle, P., Arkhis, A., Chevallier, M., Kay, A., et al. (2001) High incidence of hepatitis B infections among chronic hepatitis cases of unknown ae-tiology. Journal of Hepatology, 34, 447-454. doi:10.1016/S0168-8278(00)00100-8
[4] Castillo, I., Pardo, M., Bartolome, J., Ortiz-Movilla, N., Rodriguez-Inigo, E., de Lucas, S., et al. (2004) Occult hepatitis C virus infection in patients in whom the etiol-ogy of persistently abnormal results of liver-function tests is unknown. Journal of Infectious Diseases, 189, 7-14. doi:10.1086/380202
[5] Abdel-Aziz, F., Habib, M., Mohamed, M.K., Ab-del-Hamid, M., Gamil, F., Madkour, S., et al. (2000) Hepatitis C virus (HCV) infection in a community in the Nile Delta: Population description and HCV prevalence. Hepatology, 32, 111-115. doi:10.1053/jhep.2000.8438
[6] Nafeh, M.A., Medhat, A., Shehata, M., Mikhail, N.N., Swifee, Y., Abdel-Hamid, M., et al. (2000) Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey. American Journal of Tropical Medicine and Hygiene, 63, 236-241.
[7] El-Sadawy, M., Ragab, H., el-Toukhy, H., el-Mor Ael, L., Mangoud, A.M., Eissa, M.H., et al. (2004) Hepatitis C virus infection at Sharkia Governorate, Egypt: Sero-prevalence and associated risk factors. Journal of the Egyptian Society of Parasitology, 34, 367-384.
[8] El-Zanaty, F. and Way, A. (2009) Egypt demographic and health survey 2008. Ministry of Health, El-Zanaty and Associates and Macro International.
[9] Mezban, Z.D. and Wakil, A.E. (2006) Hepatitis C in Egypt. American Journal of Gastroenterology.
[10] Abdel-Hamid, M., Edelman, D.C., Highsmith, W.E., et al. (1997) Optimization, assessment, and proposed use of a direct nested reverse transcribtion-polymease chain reac-tion protocol for the detection of hepatitis C virus. Jour-nal of Human Virology, 1, 58-65.
[11] Bedossa, P. and Poynard, T. (1996) An algorithm for the grading of activity in chronic hepatitis C. Hepatology, 24, 289-293. doi:10.1002/hep.510240201
[12] McOmish, F., Yap, P.L., Dow, B.C., Follett, E.A., Seed, C., Keller, A.J., et al. (1994) Geographical distribution of hepatitis C virus genotypes in blood donors: An international collaborative survey. Journal of Clinical Microbiology, 32, 884-892.
[13] Constantine, N.T., Abdel-Hamid, M. and Oldach, D.W. (1995) Rapid genotyping of hepatitis C virus. New Eng-land Journal of Medicine, 333, 800. doi:10.1056/NEJM199509213331213
[14] Frank, C., Mohamed, M.K., Strickland, G.T., Lavanchy, D., Arthur, R.R., Magder, L.S., et al. (2000) The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet, 355, 887-891. doi:10.1016/S0140-6736(99)06527-7
[15] Pybus, O.G., Charleston, M.A., Gupta, S., Rambaut, A., Holmes, E.C. and Harvey, P.E. (2001) The epidemic be-haviour of the hepatitis C virus. Science, 292, 2323-2325. doi:10.1126/science.1058321
[16] Tanaka, Y., Shimoike, T., Ishii, K., Suzuki, R., Suzuki, T., Ushijima, H., et al. (2000) Selective binding of hepatitis C virus core protein to synthetic oligonucleotides corre-sponding to the 5’ untranslated region of the viral ge-nome. Virology, 270, 229-236. doi:10.1006/viro.2000.0252
[17] Zakaria, S., Fouad, R., Shaker, O., Zaki, S., Hashem, A., El-Kamary, S.S., et al. (2007) Changing patterns of acute viral hepatitis at a major urban referral center in Egypt. Clinical Infectious Diseases, 44, 30-36. doi:10.1086/511074
[18] Schmidt, W.N., Wu, P., Cederna, J., Mitros, F.A., LaBrec-que, D.R. and Stapleton, J.T. (1997) Surreptitious hepati-tis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody tests. Journal of Infectious Diseases, 176, 27-33. doi:10.1086/514033
[19] Stapleton, J.T., Schmidt, W.N. and Katz, L. (2004) Sero-negative hepatitis C virus infection, not just RNA detec-tion. Journal of Infectious Diseases, 190, 651-652. doi:10.1086/421282
[20] Saleh, A., Yousry, M., Hassan, E.S., et al. (2008) Study of the prevalence of occult Hepatitis C virus infection in patients with persistent hypertransaminasaemia of un-known etiology, and its correlation with hepatic histopa-thological change. Journal of the Egyptian Society of Parasitology.
[21] Quiroga, J.A., Castillo, I., Bartolome, J., and Carreno, V. (2007) Serum immunoglobulin G antibodies to the GOR autoepitope are present in patients with occult hepatitis C virus (HCV) infection despite lack of HCV-specific antibodies. Clinical and Vaccine Immunology, 14, 1302- 1306. doi:10.1128/CVI.00128-07
[22] Habib, M., Mohamed, M.K., Abdel Aziz, F., Magder, L.S., Abdel Hamid, M., Gamil, F., et al. (2001) Hepatitis C virus infection in a community in the Nile Delta: Risk factors for seropositivity. Hepatology, 33, 248-253. doi:10.1053/jhep.2001.20797
[23] Pardo, M., Lo′pez-Alcorocho, J.M., Rodr?′guez-In?igo, E., Castillo, I., and Carren?O, V. (2007) Comparative study between occult hepatitis C virus infection and chronic hepatitis C. Journal of Viral Hepatitis, 14, 36-40.
[24] Sanyal, A.J. (2002) AGA technical review on nonalco-holic fatty liver disease. Gastroenterology, 123, 1705- 1725. doi:10.1053/gast.2002.36572
[25] Haydon, G.H., Jarvis, L.M., Blair, C.S., Simmonds, P., Harrison, D.J., Simpson, K.J., et al. (1998) Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut, 42, 570-575. doi:10.1136/gut.42.4.570
[26] Sorbi, D., Boynton, J. and Lindor, K.D. (1999) The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steato-hepatitis from alcoholic liver disease. American Journal of Gastroenterology, 94, 1018-1022. doi:10.1111/j.1572-0241.1999.01006.x
[27] Kamal, M.S. and Nasser, A.I. (2008) Hepatitis C geno-type 4. Hepatology, 47, 1371-1383. doi:10.1002/hep.22127
[28] Genovese, D., Dettori, S., Argentini, C., Villano, U., Chionne, P., Angelico, M., et al. (2004) Molecular epi-demiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis. Journal of Clinical Microbiology, 43, 1902-1909. doi:10.1128/JCM.43.4.1902-1909.2005
[29] Seki, S., Kitada, T., Yamada, T., et al. (2002) In situ de-tection of lipid peroxidation and oxidative DNA damage in nonalcoholic fatty liver diseases. Journal of Hepatol-ogy, 37, 56-62. doi:10.1016/S0168-8278(02)00073-9
[30] Farrell, G.C. (2003) Nonalcoholic steatohepatitis: What is it, and why is it important in the Asia-Pacific region? Journal of Gastroenterology and Hepatology, 18, 124- 138. doi:10.1046/j.1440-1746.2003.02989.x
[31] Brunt, E.M. (2007) Pathology of fatty liver disease. Modern Pathology, 20, 40-48. doi:10.1038/modpathol.3800680

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.